Clinical immunology (Record no. 3606)

MARC details
000 -LEADER
fixed length control field 04784nam a22002057a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192238.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220103b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780323044042
International Standard Book Number 0323044042
040 ## - CATALOGING SOURCE
Transcribing agency CUHAS-BUGANDO
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name RKA, R. Robert
9 (RLIN) 27393
245 ## - TITLE STATEMENT
Title Clinical immunology
Remainder of title principles and practice
250 ## - EDITION STATEMENT
Edition statement 3rd Edition
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York
Name of publisher, distributor, etc. Mosby, Elsevier
Date of publication, distribution, etc. 2008
300 ## - PHYSICAL DESCRIPTION
Extent 1578 pages
520 ## - SUMMARY, ETC.
Summary, etc. In the 12 years since publication of the first edition of Clinical Immunology much has changed; as we have increasingly appreciated the nature<br/>of the molecular mechanisms underlying inflammatory responses to specific antigens, the discipline has surely become more complex, more<br/>interesting and more demanding of its practitioners. Acquired immunity, the specialized development of vertebrate host defenses, was for many<br/>decades the primary focus of attention. Recently, however, we have witnessed an explosion of information relating to the phylogenetically older<br/>systems of innate immunity, which has concurrently enlarged the purview of clinical immunology. In addition to those classical diseases of<br/>the acquired immune system, clinical immunologists today are increasingly interested in a range of inflammatory diseases where rearranged<br/>antigen-specific receptors have not been demonstrated or may not be involved. Rather than specific antigen receptors, these disorders are<br/>mediated by pathogen-recognition systems such as Toll-like receptors on NK lymphocytes and phagocytic cells. These trigger inflammatory<br/>effector processes that were later adopted by the acquired immune system, such as elaboration of soluble inflammatory mediators (cytokines<br/>and chemokines), complement activation, phagolysosome-mediated pathogen elimination and programmed cell death.<br/>The third edition reflects this improved understanding with increased attention to processes and diseases of inflammation and a broadly<br/>defined view of host defenses. We trust that this has been accomplished while retaining a principal focus on those many diseases at the core of<br/>clinical immunology arising from deficiency or aberration of functions of acquired immunity.<br/>Two changes will be immediately apparent to readers familiar with the previous editions. The third edition is, we believe, much enhanced<br/>by production in full color throughout. Clinical case photos are increased and are presented more usefully in the context of text discussion.<br/>Similarly line drawings are not only more attractive, but utilize color effectively to enrich their information content. The second obvious change<br/>is that we have chosen to publish the book in a single (albeit large) volume rather than in the previous two-volume format. We believe that<br/>by editing to reduce redundancy, judicious referencing (with an emphasis on recent reviews) and tightening presentation, the third edition is<br/>consequently more “user friendly,” eliminating the necessity to consult more than a single volume, while not compromising overall content<br/>quality or quantity. There is also a third important change that is not immediately obvious, but which will considerably enhance the long-term<br/>usefulness of the book. This third change is the intent to provide quarterly electronic updates to registered purchasers relating to key advances<br/>in clinical immunology since the publication of this edition. We are confident that such updates will help to keep the book fresh as our field<br/>advances.<br/>The process of editing a book of this size represents the combined efforts of many individuals in addition to the editors and authors. Two<br/>persons, however, warrant special thanks for their essential roles in shepherding this work to its conclusion: Martin Mellor and Randell Baker,<br/>whose efforts on behalf of the editors, authors and, finally, the readers, is gratefully acknowledged.<br/>We trust that the book continues to find a useful place on the desks and book shelves of clinical immunologists of many stripes—from the<br/>specialized practitioner of clinical immunology (either generalized or organ-system oriented), to the generalist or organ-based specialist who<br/>is interested in state-of-the-art approaches to management of inflammatory conditions, and to the fundamental immunologist interested
Expansion of summary note mechanisms of immunologic diseases. Finally, upon reviewing this comprehensive text on clinical immunology, which delves into the many and<br/>increasingly diverse areas of immune system related diseases, the editors hope that this recording of the expanse and depth of knowledge in our<br/>specialty will impart a sense of pride and possession to those clinicians and researchers who call themselves clinical immunologists
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Clinical Immunology
9 (RLIN) 27381
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   01/03/2022   EBS8076 01/03/2022 01/03/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024